Revadee Liam‐Or

528 total citations · 1 hit paper
13 papers, 388 citations indexed

About

Revadee Liam‐Or is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Revadee Liam‐Or has authored 13 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Biomaterials. Recurrent topics in Revadee Liam‐Or's work include Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (4 papers). Revadee Liam‐Or is often cited by papers focused on Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (4 papers). Revadee Liam‐Or collaborates with scholars based in United Kingdom, Hong Kong and Egypt. Revadee Liam‐Or's co-authors include Khuloud T. Al‐Jamal, Farid N. Faruqu, Julie Wang, Lizhou Xu, Adam A. Walters, Shunping Han, Danyang Li, Kerrie Venner, Rachel J. Errington and Huw D. Summers and has published in prestigious journals such as ACS Nano, Nature Nanotechnology and Biomaterials.

In The Last Decade

Revadee Liam‐Or

12 papers receiving 382 citations

Hit Papers

Cellular uptake and in vivo distribution of mesenchymal-s... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Revadee Liam‐Or United Kingdom 9 296 150 89 46 26 13 388
Yiping Weng China 12 244 0.8× 195 1.3× 98 1.1× 54 1.2× 21 0.8× 26 458
Shaobo Shan China 11 274 0.9× 118 0.8× 98 1.1× 55 1.2× 15 0.6× 15 417
Yundi Chen China 11 240 0.8× 105 0.7× 98 1.1× 36 0.8× 21 0.8× 24 354
Narges Mardi Iran 10 322 1.1× 144 1.0× 59 0.7× 39 0.8× 29 1.1× 16 408
Lvyuan Li China 8 204 0.7× 108 0.7× 113 1.3× 48 1.0× 12 0.5× 13 346
Yang Peng United States 9 216 0.7× 127 0.8× 90 1.0× 66 1.4× 40 1.5× 11 371
Piao Zhao China 9 194 0.7× 105 0.7× 82 0.9× 43 0.9× 19 0.7× 26 398
Yamei Shen China 7 189 0.6× 117 0.8× 65 0.7× 36 0.8× 75 2.9× 7 307
Jinchun Zhou China 11 197 0.7× 86 0.6× 54 0.6× 32 0.7× 37 1.4× 16 378

Countries citing papers authored by Revadee Liam‐Or

Since Specialization
Citations

This map shows the geographic impact of Revadee Liam‐Or's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Revadee Liam‐Or with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Revadee Liam‐Or more than expected).

Fields of papers citing papers by Revadee Liam‐Or

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Revadee Liam‐Or. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Revadee Liam‐Or. The network helps show where Revadee Liam‐Or may publish in the future.

Co-authorship network of co-authors of Revadee Liam‐Or

This figure shows the co-authorship network connecting the top 25 collaborators of Revadee Liam‐Or. A scholar is included among the top collaborators of Revadee Liam‐Or based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Revadee Liam‐Or. Revadee Liam‐Or is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Walters, Adam A., Yau Mun Lim, Revadee Liam‐Or, et al.. (2025). CD47 Knock‐Out Using CRISPR‐Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo. Advanced Science. 12(12). e2407262–e2407262. 5 indexed citations
2.
Abdel‐Bar, Hend Mohamed, Revadee Liam‐Or, Calvin C.L. Cheung, et al.. (2025). Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo. ACS Nano. 19(50). 42658–42674.
3.
Han, Shunping, Rifka Nurul Utami, Yue Qin, et al.. (2025). Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases. Small. 21(36). e04517–e04517. 2 indexed citations
4.
Walters, Adam A., Pedro M. Costa, Yue Qin, et al.. (2024). RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells. Journal of Controlled Release. 375. 776–787. 12 indexed citations
5.
Liam‐Or, Revadee, et al.. (2024). Polyinosinic/Polycytidylic Lipid Nanoparticles Enhance Immune Cell Infiltration and Improve Survival in the Glioblastoma Mouse Model. Molecular Pharmaceutics. 21(12). 6339–6352. 5 indexed citations
6.
Li, Yueting, Kuo‐Ching Mei, Revadee Liam‐Or, et al.. (2024). Graphene Oxide Nanosheets Toxicity in Mice Is Dependent on Protein Corona Composition and Host Immunity. ACS Nano. 18(33). 22572–22585. 15 indexed citations
7.
Liam‐Or, Revadee, Farid N. Faruqu, Adam A. Walters, et al.. (2024). Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nature Nanotechnology. 19(6). 846–855. 88 indexed citations breakdown →
8.
Graham, Rosalind, Patrycja Gazińska, Atousa Khiabany, et al.. (2023). Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes. Frontiers in Immunology. 14. 1204224–1204224. 22 indexed citations
9.
Han, Shunping, Julie Wang, Rifka Nurul Utami, et al.. (2023). Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting. Journal of Controlled Release. 357. 606–619. 24 indexed citations
10.
Man, Francis, Farid N. Faruqu, Jana Kim, et al.. (2022). PET Imaging of Small Extracellular Vesicles via [ 89 Zr]Zr(oxinate) 4 Direct Radiolabeling. Bioconjugate Chemistry. 33(3). 473–485. 36 indexed citations
11.
Xu, Lizhou, Farid N. Faruqu, Yau Mun Lim, et al.. (2020). Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. Biomaterials. 264. 120369–120369. 67 indexed citations
13.
Xu, Lizhou, Farid N. Faruqu, Revadee Liam‐Or, et al.. (2020). Design of experiment (DoE)‐driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copper‐free click chemistry‐based labelling. Journal of Extracellular Vesicles. 9(1). 1779458–1779458. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026